Costs and benefits of enforcing housing policies to prevent childhood lead poisoning

Medical Decision Making

Volumn 22, Issue 6, 2002, Pages 482-492

  Brown, Mary Jean ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cost benefit; Housing code enforcement; Lead poisoning

Indexed keywords

LEAD;

ARTICLE; CHELATION; CHILD; CHILD HEALTH; CHILDHOOD DISEASE; COST BENEFIT ANALYSIS; HEALTH CARE COST; HEALTH HAZARD; HEAVY METAL POISONING; HOUSING; HUMAN; LAW ENFORCEMENT; LEAD BLOOD LEVEL; LEAD POISONING; MONTE CARLO METHOD; PATIENT MONITORING; PROBABILITY; SAFETY; URBAN AREA;

CHILD; COST-BENEFIT ANALYSIS; HOUSING; HUMANS; LAW ENFORCEMENT; LEAD POISONING; PUBLIC POLICY; SENSITIVITY AND SPECIFICITY; UNITED STATES; URBAN HEALTH;

EID: 0036847820     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X02238298     Document Type: Article

References (51)

1. Centers for Disease Control and Prevention. Update: Blood lead levels - United States, 1991-1994. MMWR. 1997;46:141-6.
2. Brody DJ, Pirkle JL, Kramer R, et al. Blood lead levels in the US population, phase one of the Third National Health and Nutrition Examination Survey [NHANES III 1988-1991). JAMA. 1994;272:277-83.
3. Buyer R, Lord E. Late effects of lead poisoning on mental development. Am J Dis Child. 1943;66:471-94.
4. Bellinger D, Leviton A, Waternaux C, Needlemand H, Rabinowitz R. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med. 1987;316:1037-43.
5. Bornschein R, Hammond P, Dietrich K, et al. The Cincinnati prospective study of low-level lead exposure and its effect on child development: Protocol and status report. Environ Res. 1985;38:4-18.
6. Dietrich K, Krafft K, Bornschein R, et al. Low-level fetal lead exposure effect on neurobehavioral development in early infancy. Pediatrics. 1987;80(5):721-30.
7. World Health Organization. Environmental Health Criteria 165: Inorganic Lead. Geneva, Switzerland: World Health Organization; 1995.
8. Needleman HL, Gatsonis CA. Low level lead exposure and the IQ of children: A meta-analysis of modern studies. JAMA. 1990;263:673-8.
9. Lanphear B, Dietrich K, Auinger P, Cox C. Cognitive deficits associated with blood lead concentrations < 10 μg/dL in US children and adolescents. Publ Health Rep. 2000;115:521-9.
10. Needleman HL, Schell A, Bellinger D, Leviton A, and Allred E. The long term effects of exposure to low doses of lead in childhood: An 11 year follow-up report. N Engl J Med. 1990;311:83-8.
11. White R, Diamond R, Proctor S, et al. Residual cognitive deficits 50 years after lead poisoning during childhood. Brit J Industr Med. 1993;50:613-22.
12. Bellinger, D. Interpreting the literature of lead and child development: The neglected role of the experimental system. Neurotoxicol Teratol. 1995;17:201-12.
13. Dyer, F. Clinical presentation of the lead poisoned child on mental ability tests. J Clin Psych. 1993;49(1):94-101.
14. Shaheen S. Neuromaturation and behavior development: The case of childhood lead poisoning. Dev Psych. 1984;20(4):542-50.
15. Gilbert S, Rice D. Low level lifetime lead exposure produces behavioral toxicity in adult monkeys. Tox Appl Pharmacol. 1987;91:484-90.
16. Rice D. Chronic low level exposure from bith produces deficits in discrimination reversal in monkeys. Tox Appl Pharmacol. 1985;77:201-10.
17. Rice D, Gilbert S, Willes R. Neonatal low level lead exposure in monkeys: Locomotor activity, schedule-controlled behavior and the effect of amphetamine. Tox Appl Pharmacol. 1979;51:503-13.
18. Agency for Toxic Substances and Disease Registry. The Nature and Extent of Lead Poisoning in Children in the United States: A Report to Congress. Atlanta (GA): US Public Health Service, 1988.
19. Farfel MR, Chisolm JJ. Health and environmental outcomes of traditional and modified practices for abatement of residential lead-based paint. Am J Pub Health. 1990;80:1240-5.
20. Swindel S, Charney E, Brown MJ, Delaney J. Home abatement and blood lead changes in children with class III lead poisoning. Clin Pediat. 1994;536-41.
21. Weitzman M, Aschengrau A, Bellinger D, Jones R, Hamlin J, Beiser A. Lead-contaminated soil abatement and urban children's blood lead levels. JAMA. 1993;269:1647-54.
22. Brown MJ, Gardner J, Sargent J, et al. Effectiveness of housing policies to reduce children's lead exposure. Am J Pub Health. 2001;91:621-4.
23. MGL chapter 111 section 189A-199B; 105 CMR 460.00-460.90.
24. State of Rhode Island and Providence Plantations. Rules and Regulations for Lead Poisoning Prevention [R23-24.6PB]. February 1992, as amended October 1997.
25. Haddix A, Teutsch S, Shaffer P, Dunet D. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. Oxford, UK: Oxford University Press; 1996.
26. Gold M, Siegel J, Russel L, Weinstein M. Cost-Effectiveness in Health and Medicine. Oxford, UK: Oxford University Press; 1996.
27. US Department of Labor and Statistics. Most Requested Statistics. http://data.bls.gov/cgi-bin/surveymost?cu. Retrieved 14 February 2002.
28. Centers for Disease Control and Prevention. Preventing Lead Poisoning in Young Children. Atlanta (GA): US Department of Health and Human Services; 1991.
29. Centers for Disease Control and Prevention. Strategic Plan for the Elimination of Childhood Lead Poisoning. Atlanta (GA): US Department of Health and Human Services; 1991.
30. Cory-Slechta D, Weiss B, Cox C. Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy. J Pharmacol Exp Therap. 1987;243(3):804-13.
31. Brown MJ, Shenassa E, Matté T, Catlin S. Children in Illinois with elevated blood lead levels 1993-1998, and lead-related pediatric hospital admission in Illinois, 1993-1997. Pub Health Rep. 2000;115:532-6.
32. Graziano JH. Conceptual and practical advances in the measurement and clinical management of lead toxicity. Neurotoxicology. 1993;14(2-3):219-24.
33. Rogan WJ, Dietrick K, Ware JH, et al. The effect of chelation therapy with Succimer on neuropsychological development in children exposed to lead. N Engl J Med. 2001;344(19):1421-6.
34. Chaikind S, Danileson LC, Brauen ML. What do we know about special education? A selected review. J Spec Ed. 1993;26(4):344-70.
35. Alliance to End Childhood Lead Poisoning and the National Center for Lead Safe Housing. Another Link in the Chain. Washington, DC: Alliance to End Childhood Lead Poisoning and the National Center for Lead Safe Housing; 1999.
36. Drummond MF, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Toronto, Canada: Oxford University Press; 1986.
37. Clemmer B, Haddix AC. Cost-benefit analysis. In: Haddix AC, editor. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. New York: Oxford University Press; 1996.
38. Meltzer D, Egleston B, Stoffel D, et al. Effect of future costs on costeffectiveness of medical interventions among young adults. Med Care. 2000;38(6):679-85.
39. Schwatrz J. Societal benefits of reducing lead exposure. Environ Res. 1994;66:105-24.
40. Salkever D. Updated estimates of earnings benefits from reduced exposure of children to environmental lead. Environ Res. 1995;70:1-6.
41. Massachusetts Office of Tourism and Travel. Where to Stay. http://www.mass-vacation.com/jsp/all-lodging. Retrieved 20 September 1999.
42. US Department of Agriculture, Center for Nutrition Policy and Promotion. Official USDA Food Plans: Cost of Food at Home at Four Levels, US Average, June 1999. Washington: US Department of Agriculture, Center for Nutrition Policy and Promotion; 1999.
43. Doubilet P, Begg C, Weinstein M, Braun P, McNeil B. Probabilistic sensitivity analysis using Monte Carlo simulation: A practical approach. Med Decis Making. 1985;5:157-77.
44. Weinstein MC, Stasson WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296:716-21.
45. US Department of Housing and Urban Development, Office of Lead Hazard Control. National Survey of Lead and Allergens in Housing, Final Draft Report, Vol. 1: Analysis of Lead Hazards. Washington: US Department of Housing and Urban Development; 2001. Retrieved 22 July 2001 from http://www.hud.gov
46. Glotzer DE, Freedberg KA, Bauchner H. Management of childhood lead poisoning: Clinical impact and cost-effectiveness. Med Decis Making. 1995;15:13-24.
47. Hu H, Watanabe H, Payton M, et al.. The relationship of bone and blood lead to hypertension. JAMA. 1994;275:1171-6.
48. Korrick S, Hunter D, Rotnitzky A, Howard H, Spitzer FE. Lead and hypertension in a sample of middle-aged women. Am J Pub Health. 1999;89:330-5.
49. Gonzalez-Cossio T, Peterson, K, Luz-Helena S, et al. Decrease in birth weight in relation to maternal bone-lead burden. Pediatrics. 1997;100:856-62.
50. Brown MJ, Hu H, Gonzalez-Cossio T, et al. Determinants of bone and blood lead concentrations in the early postpartum period. Occup Environ Med. 2000;57:535-41.
51. Glied S. Estimating the indirect cost of illness: An assessment of the forgone earnings approach. Am J Pub Health. 1996;86:1723-8.